We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UiPath Slides 24% After Q2 Earnings: Is PATH Stock a Buy?
Read MoreHide Full Article
Key Takeaways
UiPath shares fell 24% despite Q2 revenues beating expectations and full-year guidance being raised.
PATH's ARR rose 12.5% year over year, while AI featured in 18 of the quarter's 20 largest deals.
UiPath posted a fourth straight GAAP-profitable quarter and ended Q2 with $1.405 billion in cash.
UiPath’s (PATH - Free Report) latest results merit another look after the market has had time to digest them. Shares have fallen 24% since the Sept. 3 release, even though second-quarter fiscal 2027 revenues exceeded expectations and management lifted its annual targets.
The reaction appears less about the reported quarter than the outlook’s magnitude and composition: the fiscal third-quarter revenue midpoint sits below the consensus mark, while the modest ARR-guidance increase leaves investors waiting for clearer AI-driven acceleration. That reset, however, creates a more interesting entry point, provided execution continues.
Image Source: Zacks Investment Research
PATH’s YoY Revenue Growth Beats Expectations
Fiscal second-quarter revenues rose 13.4% year over year to $410.3 million, beating the $397.8 million consensus mark by 3.1%. Revenues nevertheless have declined 1.9% sequentially from $418.4 million. License revenues increased 10.4% year over year to $123.8 million but fell 17.1% from the fiscal first quarter.
Subscription-services revenues advanced 11.6% year over year and 5.2% sequentially to $266.1 million, improving the recurring-revenue mix. Professional services and other revenues surged 81.6% year over year and 25.8% quarter over quarter to $20.3 million, although they remained a small contributor.
GAAP gross profit increased 10.9% year over year but declined 3.5% sequentially to $329.7 million. The corresponding gross margin was 80%, down two percentage points both year over year and sequentially. Non-GAAP gross margin similarly contracted to 82% from 84% a year ago and 83% in the prior quarter.
Lower operating expenses offset that pressure. GAAP operating income reached $31.6 million, reversing a $20.2 million loss a year earlier and rising 12.9% sequentially. Operating margin improved to 8% from negative 6% and 7% in the prior year and prior quarter, respectively. This marked UiPath’s fourth consecutive quarter of GAAP profitability.
Non-GAAP operating income climbed 42.9% year over year to $89 million, though it slipped 3.7% sequentially. Its 22% margin expanded five percentage points year over year and held steady quarter over quarter. Adjusted earnings were 15 cents per share, unchanged both year over year and sequentially.
ARR Gains Support the AI Thesis, but Acceleration Is Still Needed
ARR reached $1.938 billion, up 12.5% year over year and 1.9% sequentially. Net new ARR was $37 million, 19.4% above the prior-year quarter but 24.5% below the first quarter’s $49 million. Dollar-based net retention was 109%, improving one percentage point year over year and remaining flat sequentially. Gross retention held at 97%, with attrition concentrated among smaller customers.
Image Source: Zacks Investment Research
AI appeared in 18 of the quarter’s 20 largest deals, suggesting it is becoming central to enterprise purchases. UiPath’s proposition combines probabilistic AI with rules-based automation, while model neutrality and integrations with major coding assistants broaden its relevance. Larger outcome-oriented contracts could lift deal sizes, but evolving transaction-based pricing makes near-term monetization less predictable.
Raised Guidance Is Positive, Yet the Upside Looks Measured
Fiscal third-quarter revenue guidance of $440-$445 million has a $442.5 million midpoint, lower than the $444.3 million Zacks Consensus Estimate. ARR is projected at $1.992-$1.997 billion, implying 2.9% sequential growth at the midpoint, while non-GAAP operating income of roughly $100 million suggests a margin near 22.6%.
Full-year revenue guidance increased to $1.789-$1.794 billion from $1.776-$1.781 billion, representing a 0.7% midpoint raise and higher than the current Zacks Consensus Estimate of $1.78 billion. The ARR range moved up just 0.3% at the midpoint to $2.065-$2.070 billion, while non-GAAP operating-income guidance rose 3.5% to $445 million. Adjusted free cash flow is expected to approximate $425 million. The sharper profit revision is encouraging, but the restrained ARR increase helps explain why the market focused on competitive AI risk rather than the headline beat.
ServiceNow and Salesforce Set a Demanding Competitive Bar
ServiceNow (NOW - Free Report) and Salesforce (CRM - Free Report) provide useful benchmarks for UiPath’s AI-automation opportunity. ServiceNow embeds AI agents and workflow orchestration across its enterprise platform, giving it a large installed-base advantage and substantial cross-selling reach. Salesforce similarly connects autonomous agents with customer data, applications and workflows through Agentforce, making it a formidable competitor for enterprise automation budgets.
Yet UiPath retains differentiation in deterministic robotic automation, model neutrality and governance across mixed human, software and agent processes. ServiceNow may appeal to customers standardizing IT workflows, while Salesforce is strongest around customer-facing processes. UiPath’s opportunity lies in serving as the controlled execution layer across both domains, especially for complex, regulated operations over the coming investment cycle.
Cash Generation Moderated, but the Balance Sheet Remains Strong
Operating cash flow fell 26.2% year over year and 76.7% sequentially to $30.7 million. Adjusted free cash flow was about $31 million, down 31.1% year over year and 76.2% sequentially, reflecting quarterly timing following a strong first quarter.
UiPath still ended the period with $1.405 billion in cash and investments, down only 1.1% sequentially, and no debt. It also repurchased 2.4 million shares at an average price of $9.63, providing modest support while preserving substantial financial flexibility.
Verdict: The Selloff Makes PATH a Buy
The post-earnings decline has created an attractive entry point for investors willing to tolerate volatility. UiPath is pairing durable recurring-revenue growth with stronger retention, disciplined spending and sustained profitability, while its debt-free balance sheet provides room to keep investing. The market’s concern that general-purpose AI tools could erode traditional automation demand is legitimate, and near-term growth remains measured. However, enterprises still require accuracy, governance and orchestration when automated decisions reach core operations. UiPath’s model-neutral platform is designed for precisely that need. With execution improving and expectations reset after the selloff, the risk-reward balance supports a Buy for patient investors today.
Image: Bigstock
UiPath Slides 24% After Q2 Earnings: Is PATH Stock a Buy?
Key Takeaways
UiPath’s (PATH - Free Report) latest results merit another look after the market has had time to digest them. Shares have fallen 24% since the Sept. 3 release, even though second-quarter fiscal 2027 revenues exceeded expectations and management lifted its annual targets.
The reaction appears less about the reported quarter than the outlook’s magnitude and composition: the fiscal third-quarter revenue midpoint sits below the consensus mark, while the modest ARR-guidance increase leaves investors waiting for clearer AI-driven acceleration. That reset, however, creates a more interesting entry point, provided execution continues.
PATH’s YoY Revenue Growth Beats Expectations
Fiscal second-quarter revenues rose 13.4% year over year to $410.3 million, beating the $397.8 million consensus mark by 3.1%. Revenues nevertheless have declined 1.9% sequentially from $418.4 million. License revenues increased 10.4% year over year to $123.8 million but fell 17.1% from the fiscal first quarter.
Subscription-services revenues advanced 11.6% year over year and 5.2% sequentially to $266.1 million, improving the recurring-revenue mix. Professional services and other revenues surged 81.6% year over year and 25.8% quarter over quarter to $20.3 million, although they remained a small contributor.
PATH’s Margin Expansion Confirms Better Operating Discipline
GAAP gross profit increased 10.9% year over year but declined 3.5% sequentially to $329.7 million. The corresponding gross margin was 80%, down two percentage points both year over year and sequentially. Non-GAAP gross margin similarly contracted to 82% from 84% a year ago and 83% in the prior quarter.
Lower operating expenses offset that pressure. GAAP operating income reached $31.6 million, reversing a $20.2 million loss a year earlier and rising 12.9% sequentially. Operating margin improved to 8% from negative 6% and 7% in the prior year and prior quarter, respectively. This marked UiPath’s fourth consecutive quarter of GAAP profitability.
Non-GAAP operating income climbed 42.9% year over year to $89 million, though it slipped 3.7% sequentially. Its 22% margin expanded five percentage points year over year and held steady quarter over quarter. Adjusted earnings were 15 cents per share, unchanged both year over year and sequentially.
ARR Gains Support the AI Thesis, but Acceleration Is Still Needed
ARR reached $1.938 billion, up 12.5% year over year and 1.9% sequentially. Net new ARR was $37 million, 19.4% above the prior-year quarter but 24.5% below the first quarter’s $49 million. Dollar-based net retention was 109%, improving one percentage point year over year and remaining flat sequentially. Gross retention held at 97%, with attrition concentrated among smaller customers.
AI appeared in 18 of the quarter’s 20 largest deals, suggesting it is becoming central to enterprise purchases. UiPath’s proposition combines probabilistic AI with rules-based automation, while model neutrality and integrations with major coding assistants broaden its relevance. Larger outcome-oriented contracts could lift deal sizes, but evolving transaction-based pricing makes near-term monetization less predictable.
Raised Guidance Is Positive, Yet the Upside Looks Measured
Fiscal third-quarter revenue guidance of $440-$445 million has a $442.5 million midpoint, lower than the $444.3 million Zacks Consensus Estimate. ARR is projected at $1.992-$1.997 billion, implying 2.9% sequential growth at the midpoint, while non-GAAP operating income of roughly $100 million suggests a margin near 22.6%.
Full-year revenue guidance increased to $1.789-$1.794 billion from $1.776-$1.781 billion, representing a 0.7% midpoint raise and higher than the current Zacks Consensus Estimate of $1.78 billion. The ARR range moved up just 0.3% at the midpoint to $2.065-$2.070 billion, while non-GAAP operating-income guidance rose 3.5% to $445 million. Adjusted free cash flow is expected to approximate $425 million. The sharper profit revision is encouraging, but the restrained ARR increase helps explain why the market focused on competitive AI risk rather than the headline beat.
ServiceNow and Salesforce Set a Demanding Competitive Bar
ServiceNow (NOW - Free Report) and Salesforce (CRM - Free Report) provide useful benchmarks for UiPath’s AI-automation opportunity. ServiceNow embeds AI agents and workflow orchestration across its enterprise platform, giving it a large installed-base advantage and substantial cross-selling reach. Salesforce similarly connects autonomous agents with customer data, applications and workflows through Agentforce, making it a formidable competitor for enterprise automation budgets.
Yet UiPath retains differentiation in deterministic robotic automation, model neutrality and governance across mixed human, software and agent processes. ServiceNow may appeal to customers standardizing IT workflows, while Salesforce is strongest around customer-facing processes. UiPath’s opportunity lies in serving as the controlled execution layer across both domains, especially for complex, regulated operations over the coming investment cycle.
Cash Generation Moderated, but the Balance Sheet Remains Strong
Operating cash flow fell 26.2% year over year and 76.7% sequentially to $30.7 million. Adjusted free cash flow was about $31 million, down 31.1% year over year and 76.2% sequentially, reflecting quarterly timing following a strong first quarter.
UiPath still ended the period with $1.405 billion in cash and investments, down only 1.1% sequentially, and no debt. It also repurchased 2.4 million shares at an average price of $9.63, providing modest support while preserving substantial financial flexibility.
Verdict: The Selloff Makes PATH a Buy
The post-earnings decline has created an attractive entry point for investors willing to tolerate volatility. UiPath is pairing durable recurring-revenue growth with stronger retention, disciplined spending and sustained profitability, while its debt-free balance sheet provides room to keep investing. The market’s concern that general-purpose AI tools could erode traditional automation demand is legitimate, and near-term growth remains measured. However, enterprises still require accuracy, governance and orchestration when automated decisions reach core operations. UiPath’s model-neutral platform is designed for precisely that need. With execution improving and expectations reset after the selloff, the risk-reward balance supports a Buy for patient investors today.
PATH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.